Recombinant human interleukin-1α increases serum albumin, Gc-globulin, and α1-antitrypsin levels in burned mice

被引:5
|
作者
Koike, K [1 ]
Shinozawa, Y
Yamazaki, M
Endo, T
Nomura, R
Aiboshi, J
Samarghandian, S
Emmett, M
Peterson, VM
机构
[1] Tohoku Univ, Dept Emergency & Crit Care Med, Grad Sch Med, Sendai, Miyagi 9808574, Japan
[2] Nippon Med Coll, Dept Emergency & Crit Care Med, Tokyo 1138603, Japan
[3] Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver, CO 80262 USA
来源
关键词
thermal injury; acute phase proteins;
D O I
10.1620/tjem.198.23
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The response to thermal injury is a complex physiologic process requiring communication between sites of injury and distant target organs. The liver, one of these target organs, synthesizes a family of secretory proteins, the acute phase proteins, that carries out specific immunoprotective functions. In this study we the effects of daily recombinant human interleukin-lalpha (rhIL-1alpha) administration on the serum levels of negatively regulated, i.e., albumin and Gc-globulin and positively regulated, i.e., alpha(1)-antitrypsin, acute phase proteins in a murine model of thermal injury. Adult CF-1 female mice underwent a 6.5-seconds, 20% total burn surface area, full thickness steam injury, and received either intraperitoneal rhIL-1alpha (20 mug . kg(-1) . day(-1)) or diluent for 10 days. Seven and 14 days after injury, mice were sacrificed, and serum albumin, Gc-globulin and alpha(1)-antitrypsin levels were measured by crossed immunoelectrophoresis technique. Thermal injury significantly lowered serum albumin levels, tended to decrease Gc-globulin levels, and increased serum alpha(1)-antitrypsin levels. Daily rhIL-1alpha administration after burn injury prevented hypoalbuminemia, and increased serum levels of Gc-globulin and alpha(1)-antitrypsin. IL-1 therapy might be helpful to maintain the homeostasis and immunity of the host after thermal injury.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 50 条
  • [31] EFFECTS OF RECOMBINANT INTERLEUKIN-1 AND INTERLEUKIN-2 ON HUMAN KERATINOCYTES
    MORHENN, VB
    WASTEK, GJ
    CUA, AB
    MANSBRIDGE, JN
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 93 (01) : 121 - 126
  • [32] Effects of treatment with interleukin-1 receptor antagonist on endogenous interleukin-1 levels in normal and irradiated mice
    Bugarski, D
    Jovcic, G
    Kataranovski, M
    Ivanovic, Z
    Petakov, M
    Stojanovic, N
    Milenkovic, P
    PHYSIOLOGICAL RESEARCH, 2000, 49 (03) : 355 - 362
  • [33] Commercial α1-antitrypsin preparations markedly differ in their potential to inhibit the ATP-induced release of monocytic interleukin-1β
    Agne, A.
    Richter, K.
    Padberg, W.
    Janciauskiene, S.
    Grau, V
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2021, 68
  • [34] Genotyping of human α1-Antitrypsin "P" allele variants from serum.
    Bornhorst, JA
    Procter, M
    Tang, W
    Swenson, S
    Ashwood, ER
    Mao, R
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 124 (03) : 464 - 465
  • [35] INDUCTION OF AN ACUTE EROSIVE MONARTICULAR ARTHRITIS IN MICE BY INTERLEUKIN-1 AND METHYLATED BOVINE SERUM-ALBUMIN
    STAITE, ND
    RICHARD, KA
    ASPAR, DG
    FRANZ, KA
    GALINET, LA
    DUNN, CJ
    ARTHRITIS AND RHEUMATISM, 1990, 33 (02): : 253 - 260
  • [36] Growth characteristics of rice cell genetically modified for recombinant human α1-antitrypsin production
    Terashima, M
    Hashikawa, N
    Hattori, M
    Yoshida, H
    BIOCHEMICAL ENGINEERING JOURNAL, 2002, 12 (02) : 155 - 160
  • [37] RECOMBINANT HUMAN INTERLEUKIN-1 STIMULATES CHONDROCYTES TO PRODUCE A METALLOPROTEINASE
    SCHNYDER, J
    PAYNE, T
    DINARELLO, CA
    CALCIFIED TISSUE INTERNATIONAL, 1986, 38 (NS) : S39 - S39
  • [38] Serum Interleukin-1 Levels Are Associated with Intracranial Aneurysm Instability
    Qingyuan Liu
    Peng Liu
    Yisen Zhang
    Mahmud Mossa-Basha
    David M. Hasan
    Jiangan Li
    Chengcheng Zhu
    Shuo Wang
    Translational Stroke Research, 2024, 15 : 433 - 445
  • [39] STUDIES ON THE BIOLOGICAL PROPERTIES OF PURIFIED AND RECOMBINANT HUMAN INTERLEUKIN-1
    DINARELLO, CA
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1986, 8 (02): : 57 - 61
  • [40] MULTIPLE BIOLOGICAL PROPERTIES OF RECOMBINANT HUMAN INTERLEUKIN-1 (BETA)
    DINARELLO, CA
    IMMUNOBIOLOGY, 1986, 172 (3-5) : 301 - 315